Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Postmortem Imaging × Other solid neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Interventions

Cisplatin 131 pembrolizumab 106 Carboplatin 105 Paclitaxel 87 Injections 86 Pemetrexed 82 Gemcitabine 73 Irinotecan 64 Cyclophosphamide 62 Docetaxel 58 Nivolumab 57 Bevacizumab 54 Fluorouracil 46 Capecitabine 43 Oxaliplatin 42 atezolizumab 39 Leucovorin 39 tislelizumab 36 Etoposide 34 toripalimab 28 fludarabine 27 Ipilimumab 27 Topotecan 24 Radiotherapy 24 durvalumab 23 Drug Therapy 23 olaparib 21 Vincristine 21 Specimen Handling 21 Sorafenib 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04079283 2020-04-02

RIREP

Tianjin Medical University Cancer Institute and Hospital

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡